Latest filing published 14 Nov 2022 for Emerald Health Therapeutics, Inc..
No signal scores available.
This profile gathers the share dealings of Skye Bioscience, Inc. in Emerald Health Therapeutics, Inc. Altogether 2 filings, all relating to 10 November 2022.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 14 November 2022 came the latest disclosure, a transaction in Emerald Health Therapeutics, Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations